Efficacy and safety of twice-weekly and thrice-weekly dutasteride in men with androgenetic alopecia: A randomized, investigator-blind, active-controlled, parallel-group pilot study
Published: 25 March 2025| Version 3 | DOI: 10.17632/j4rhsfvfdz.3
Contributor:
Description
Mendeley supplemental figures and table to accompany manuscript: Efficacy and safety of twice-weekly and thrice-weekly dutasteride in men with androgenetic alopecia: A randomized, investigator-blind, active-controlled, parallel-group pilot study.
Files
Institutions
Srinakharinwirot University
Categories
Dermatology, Dutasteride, Hair Disorder